THE NEWEST Medical
Breakthrough for Male Pattern Hair loss it’s original use was as eyedrops for gluacoma…..Bimatoprost (Lumigan or Latisse) may be the next medical breakthrough for hair loss treatment since FDA’s approval of Propecia, although Bimatoprost is not a hair loss drug.
be the answer!
Use as a topical treatment for male baldness or as an adjunctive treatment
along with Avodart / Propecia and Minoxidil
- Latisse (bimatoprost) is the FIRST & ONLY FDA approved medical treatment proven to enhance the length and thickness of eyelashes.
- Latisse was just unanimously approved by
the FDA as safe and effective in December 2008 for eyelash growth.- Allergan has completed Phase I safety trials of Latisse (bimatoprost) for male baldness and has begun Phase I/III efficacy trials.
- Latisse (bimatoprost) works gradually and remarkably from the inside out. You will begin to see changes in scalp hair length, thickness and darkness gradually.
- Bimatoprost is a prostaglandin analog and
is believed to affect the growth of hair follicles by increasing the ratio of hairs in the growth phase of the hair cycle and extending this phase.- Currently Latisse or Lumigan is not FDA approved for male pattern baldness, can be prescribed as an Off-Label use since Allergan has completed FDA Phase I safety trials.